Carrie J. Ngongo

May 1, 2024 | tobaccocontrol.bmj.com | Nathan Mann |Garrison Spencer |Brian Hutchinson |Carrie J. Ngongo

WHAT IS ALREADY KNOWN ON THIS TOPIC HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Introduction Tobacco use results in premature death, illness, increased healthcare costs and economic losses.1 Numerous diseases, such as cancer, cardiovascular disease and lung disease, are caused by tobacco use.2 The life expectancy for people who smoke is up to 10 years shorter than people who do not smoke.3 Tobacco use harms people who consume tobacco products as well as people who are exposed to...

May 1, 2024 | tobaccocontrol.bmj.com | Rachel Nugent |Brian Hutchinson |Nathan Mann |Carrie J. Ngongo

DiscussionInvestment case methodology varies across global health topics and over time, as new models have been developed and new data become available that allow more comprehensive and country-tailored analysis. The WHO FCTC investment cases discussed in this series advance the field in several ways. Notably, they offer comparable results from a demand-driven process of strengthening tobacco control.